Salveen Richter

Stock Analyst at Goldman Sachs

(2.37)
# 2,499
Out of 4,893 analysts
202
Total ratings
41.96%
Success rate
-0.27%
Average return

Stocks Rated by Salveen Richter

Sarepta Therapeutics
Jun 17, 2025
Downgrades: Neutral
Price Target: $29
Current: $19.07
Upside: +52.11%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $22.75
Upside: +62.64%
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51$44
Current: $4.35
Upside: +911.49%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53$47
Current: $59.00
Upside: -20.34%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15$13
Current: $9.54
Upside: +36.27%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124$104
Current: $58.82
Upside: +76.81%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37$41
Current: $25.88
Upside: +58.42%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12$9
Current: $6.30
Upside: +42.86%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9$10
Current: $12.08
Upside: -17.22%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917$804
Current: $559.76
Upside: +43.63%
Maintains: Buy
Price Target: $219$197
Current: $135.33
Upside: +45.57%
Maintains: Neutral
Price Target: $36$32
Current: $19.53
Upside: +63.85%
Maintains: Buy
Price Target: $20$18
Current: $3.73
Upside: +382.57%
Maintains: Neutral
Price Target: $85$96
Current: $114.54
Upside: -16.19%
Downgrades: Neutral
Price Target: $99$51
Current: $34.28
Upside: +48.77%
Maintains: Buy
Price Target: $45$40
Current: $15.35
Upside: +160.59%
Maintains: Neutral
Price Target: $20$12
Current: $12.16
Upside: -1.32%
Maintains: Neutral
Price Target: $9$20
Current: $14.88
Upside: +34.41%
Maintains: Neutral
Price Target: $63$70
Current: $70.34
Upside: -0.48%
Upgrades: Buy
Price Target: $198$370
Current: $322.58
Upside: +14.70%
Maintains: Buy
Price Target: $67$76
Current: $31.04
Upside: +144.88%
Maintains: Sell
Price Target: $33$37
Current: $42.38
Upside: -12.69%
Maintains: Neutral
Price Target: $19$11
Current: $9.21
Upside: +19.50%
Maintains: Neutral
Price Target: $33$53
Current: $39.57
Upside: +33.94%
Maintains: Buy
Price Target: $313$350
Current: $300.37
Upside: +16.52%
Maintains: Buy
Price Target: $442$559
Current: $479.53
Upside: +16.57%
Maintains: Neutral
Price Target: $4.5$5
Current: $14.65
Upside: -65.87%
Maintains: Buy
Price Target: $35$31
Current: $1.26
Upside: +2,360.32%
Maintains: Overweight
Price Target: $257$225
Current: $286.11
Upside: -21.36%
Initiates: Neutral
Price Target: $22
Current: $4.69
Upside: +369.08%
Downgrades: Neutral
Price Target: n/a
Current: $9.70
Upside: -
Maintains: Neutral
Price Target: $60$30
Current: $4.83
Upside: +521.12%
Maintains: Neutral
Price Target: $8$9
Current: $5.72
Upside: +57.48%
Downgrades: Neutral
Price Target: $16$3
Current: $2.55
Upside: +17.65%
Downgrades: Sell
Price Target: $15$12
Current: $22.06
Upside: -45.60%
Maintains: Neutral
Price Target: $7$6
Current: $4.06
Upside: +47.78%
Maintains: Neutral
Price Target: $39$43
Current: $62.56
Upside: -31.27%
Maintains: Sell
Price Target: $3$2
Current: $1.65
Upside: +21.21%
Maintains: Sell
Price Target: $125$100
Current: $9.54
Upside: +948.77%
Upgrades: Buy
Price Target: $28$30
Current: $0.40
Upside: +7,447.17%
Maintains: Neutral
Price Target: $57$50
Current: $99.22
Upside: -49.61%
Initiates: Neutral
Price Target: $45
Current: $18.86
Upside: +138.60%